This week, we revisit the 2014 Biopharmaceutical Development
and Production Week (BDP Week) with Tina Larson, Senior Director of Technical
Development Operations and Engineering at Genentech.
Ms. Larson takes some time to speak with interviewers about what
she believes is needed in the current biopharmaceutical manufacturing industry,
and where she sees the industry going well into the future.
According to Larson, there are four major opportunities for
innovation in her industry:
Improving the consistency of the manufacturing
processes
Looking at better drug delivery systems to
improve outcomes for patients
Developing increasingly sophisticated medicines
for patients
And improving facilities where products are made
in order to meet the needs of future product requirements
Despite Larson’s enthusiasm for these innovative opportunities,
she also mentions some challenges facing the industry:
The delivery of new, highly sophisticated medicines
to a market place has increasing pressures
These pressures include increasingly tailored
patient populations and the need to go global
When speaking of global expansion,
Larson mentioned, “Patients in the U.S have had access to these sophisticated
medicines, and now we really have an opportunity to take these medicines to
every patient who needs them across the globe.”
She hopes to see this global expansion very soon.
Tina Larson has observed the
growth of her industry first-hand over her almost two decades at Genentech. She has particularly seen massive change in
biopharmaceutical manufacturing over the last five years.
Watch Tina’s interview at: http://bit.ly/1iQQpZ9
No comments:
Post a Comment